ARK Genomic Revolution ETF
ARKG
505 hedge funds and large institutions have $2.24B invested in ARK Genomic Revolution ETF in 2021 Q1 according to their latest regulatory filings, with 159 funds opening new positions, 227 increasing their positions, 90 reducing their positions, and 62 closing their positions.
156% more first-time investments, than exits
New positions opened: 159 | Existing positions closed: 62
152% more repeat investments, than reductions
Existing positions increased: 227 | Existing positions reduced: 90
22% more capital invested
Capital invested by funds: $1.83B → $2.24B (+$404M)
22% more funds holding
Funds holding: 414 → 505 (+91)
0.37% more ownership
Funds ownership: 24.54% → 24.9% (+0.37%)
37% less funds holding in top 10
Funds holding in top 10: 27 → 17 (-10)
56% less call options, than puts
Call options by funds: $474M | Put options by funds: $1.08B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FP
Financial Perspectives
Minneapolis,
Minnesota
|
+$147M |
| 2 |
SDH
Sloy Dahl & Holst
Vancouver,
Washington
|
+$135M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$88.1M |
| 4 |
EP
Eversept Partners
New York
|
+$80M |
| 5 |
Morgan Stanley
New York
|
+$77.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$63.2M |
| 2 |
MCM
Mainstay Capital Management
Grand Blanc,
Michigan
|
-$39.4M |
| 3 |
SM
SG3 Management
Dorado,
Puerto Rico
|
-$22.5M |
| 4 |
UAM
UAS Asset Management
New York
|
-$19.2M |
| 5 |
LFA
Legend Financial Advisors
Pittsburgh,
Pennsylvania
|
-$18.5M |
ARKG Hedge Fund Activity: Q1 2021 in Review
505 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q1 2021, worth a combined $2.24B — up 22% from $1.83B a quarter earlier.
Buyers outnumbered sellers: 159 funds opened new ARKG positions and 62 closed out — a net gain of 97 holders — while 227 added to existing stakes and 90 trimmed.
The largest buyer was Financial Perspectives, adding an estimated $147M. The largest seller was Jane Street, cutting an estimated $63.2M.
- 505 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q1 2021, up from 414 in Q4 2020.
- Funds reported $2.24B of ARK Genomic Revolution ETF stock for Q1 2021, up 22% quarter-over-quarter.
- 159 funds opened new ARK Genomic Revolution ETF positions in Q1 2021 and 62 closed out, a net change of +97 holders.
- The largest ARK Genomic Revolution ETF buyer in Q1 2021 was Financial Perspectives, an estimated $147M added.
- The largest ARK Genomic Revolution ETF seller in Q1 2021 was Jane Street, an estimated $63.2M sold.
Based on aggregated 13F filings for Q1 2021.